JCRB1601 EMTOKA
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1601 | Cell Name | EMTOKA |
---|---|---|---|
Profile | Human cell line derived from uterine carcinosarcoma. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 64-year-old |
Identity | available | Tissue for Primary Cancer | uterus |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | ||
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | The cells transplantable to nude mice. |
Classify | tumor | Established by | Gorai, I. |
Registered by | Gorai, I. | Regulation for Distribution | |
Comment | Year | 2013 | |
Medium | RPMI1640 medium with 10% fetal bovine serum | Methods for Passages | Cells are harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Cell Number on Passage | 1-3 x 10^4 cells/mL | Race | |
CO2 Conc. | 5% | Tissue Sampling | Uterine body |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:9311600 | Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. Gorai I,Yanagibashi T,Taki A,Udagawa K,Miyagi E,Nakazawa T,Hirahara F,Nagashima Y,Minaguchi H Int J Cancer. 1997 Sep 4;72(5):821-7 |
Pubmed id:8431860 | Establishment and characterization of carcinosarcoma cell line of the human uterus. Gorai I,Doi C,Minaguchi H Cancer. 1993 Feb 1;71(3):775-86 |
Images |
---|
LOT Information
Cell No. | JCRB1601 | Cell Name | EMTOKA |
---|---|---|---|
LOT No. | 08052014 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
Cell Density at Seeding | 0.57-2.65x10^4cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
Doubling Time | nT | Cell Number in Vial (cells/1ml) | 1.23x10^6 |
Viability at cell freezing (%) | 95.1 | Antibiotics Used | free |
Passage Number | p4* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9,11 D13S317:11,13 D7S820:10 D16S539:9,12 VWA:17,18 TH01:9 AM:X TPOX:8,11 CSF1PO:10,11 |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB1601 | Cell Name | EMTOKA |
---|---|---|---|
LOT No. | 11242020 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (FBS; Biowest Cat. # S1820-500) | Temperature | 37 C |
Cell Density at Seeding | 3.9 - 5.2 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 41 hrs. | Cell Number in Vial (cells/1ml) | 1.4 x 10^6 |
Viability at cell freezing (%) | 97 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 96 | Additional information |